FDA Must Consider Alternatives to Laboratory Developed Test Proposals
What’s Happening: CHA submitted comments to the Food & Drug Administration (FDA) on proposed regulation of laboratory developed tests (LDTs).
What Else to Know: The proposed rule would have significant unintended consequences for the delivery of medical laboratory services and would raise costs to the overall health care system.